Browsing Tag
Piramal Pharma Limited
5 posts
Piramal Pharma (NSE: PPLPHARMA) jumps 17%. Why is profit only Rs 5cr?
Piramal Pharma shares surged after a surprise return to quarterly profitability, 28% revenue growth and an upgraded FY2027 outlook. But high tax expenses, rising debt and a first-half loss raise a crucial question about how much of the operating recovery can reach shareholders.
Can Piramal Pharma Solutions’ ADCelerate platform gain an edge with IntoCell’s linker-payload tech?
Piramal Pharma Solutions teams up with IntoCell to expand ADCelerate platform and access cutting-edge linker-payload tech. Explore how this reshapes the CDMO landscape.
Piramal Pharma expands into paediatric critical care with UK approval for Neoatricon
Piramal Pharma’s Neoatricon secures UK approval, revolutionizing paediatric critical care. Learn how this breakthrough will reshape neonatal hypotension treatment.
Piramal Pharma posts robust Q2 growth, expands Lexington facility to meet demand
Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635) has reported strong growth for the second quarter (Q2) and…
Piramal Pharma enters men’s grooming market with BOHEM range
Piramal Pharma Limited’s Consumer Products Division (CPD) has announced its entry into the men’s personal grooming sector, launching…